Clinical Trial of COVID-19 Convalescent Plasma in Outpatients (C3PO)
收藏NIAID Data Ecosystem2026-04-30 收录
官方服务：
资源简介：
The Clinical Trial of COVID-19 Convalescent Plasma in Outpatients (C3PO) is a multicenter, randomized, single blind, two-arm, placebo controlled Phase III trial with blinded outcome assessments to establish the safety and efficacy of single dose of convalescent plasma for preventing the progression from mild to severe COVID-19 illness.]]>
创建时间：
2021-12-23
